Pediatria Polska

Abstract

3/2020 vol. 95
Case report

Gordon syndrome in an 11-year-old boy: long-term follow-up

  1. Chair and Department of Paediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
  2. Department of Paediatrics, District Hospital in Zawiercie, Poland
  3. Department of Paediatric Nephrology with Dialysis Division for Children, Independent Public Clinical Hospital No. 1, Zabrze, Poland
Pediatr Pol 2020; 95 (3): 184–190
Online publish date: 2020/10/30
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Gordon syndrome, or type 2 pseudohypoaldosteronism, is a rare familial occurring hypertension, in most cases inherited in an autosomal dominant manner. It is characterised by coexisting hyperkalaemia, which is not found in other monogenic forms of hypertension. In addition, in this syndrome aldosterone levels are usually low, and renin activity is reduced under normal salt loading. Renal function, assessed on the basis of glomerular filtration rate, is normal, but metabolic acidosis – type IV renal tubular acidosis – may occur. The authors would like to present the case of an 11-year-old boy in whom the above-described symptoms of Gordon syndrome were observed; clinically effective thiazide diuretic therapy, and subsequent genetic analysis confirmed the diagnosis.
Share
without publication fees
without publication fees